Old Web
English
Sign In
Acemap
>
authorDetail
>
Kazuhiro Shibayama
Kazuhiro Shibayama
Janssen Pharmaceutica
Medicine
Internal medicine
Oncology
Placebo
Phases of clinical research
4
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study
2020
International Journal of Hematology
Hiroyuki Takamatsu
Shinsuke Iida
Hirohiko Shibayama
Kazuhiro Shibayama
Hiroshi Yamazaki
Kenshi Suzuki
Show All
Source
Cite
Save
Citations (6)
Efficacy and safety of apalutamide in Japanese patients with non-metastatic castration-resistant prostate cancer: A subgroup analysis of a randomized, double-blind, placebo-controlled, phase 3 study
2020
Prostate international
Hiroji Uemura
Takefumi Satoh
Hideyasu Tsumura
Gaku Arai
Keiichiro Imanaka
Kazuhiro Shibayama
Koji Fujii
Brendan Rooney
Angela Lopez-Gitlitz
Byron M. Espina
Carlos Perez Ruixo
Eric J. Small
Matthew R. Smith
Show All
Source
Cite
Save
Citations (4)
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study
2018
Japanese Journal of Clinical Oncology
Hiroyoshi Suzuki
Toshitaka Shin
Satoshi Fukasawa
Katsuyoshi Hashine
Sumiko Kitani
Noriyuki Ohtake
Kazuhiro Shibayama
Namphuong Tran
Suneel Mundle
Karim Fizazi
Nobuaki Matsubara
Show All
Source
Cite
Save
Citations (17)
1